HB1 Stock Chart & Stats
€49.20
€0.80(1.65%)
At close: 4:00 PM EDT
€49.20
€0.80(1.65%)
Day’s Range― - ―
52-Week Range€42.00 - €57.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€2.41B
Enterprise Value€5.05B
Total Cash (Recent Filing)€97.23M
Total Debt (Recent Filing)€2.05B
Price to Earnings (P/E)13.9
Beta0.77
Next Earnings
Jan 20, 2027EPS Estimate
1.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.64
Shares Outstanding53,829,120
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.21
Price to Book (P/B)1.59
Price to Sales (P/S)0.92
P/FCF Ratio26.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€56.30Price Target Upside14.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)4.34
Revenue Forecast (FY)€3.20B
Bulls Say, Bears Say
Bulls Say
Sustainable Margin Expansion Through Pricing And RestructuringPricing discipline and restructuring savings are improving profitability despite inflation and lower volumes. This indicates stronger earnings quality and suggests the company can protect margins through customer value, specialty formulations, and ongoing operational efficiency over the next several quarters.
Quantum Leap Offers Recurring Cost And Cash-flow BenefitsThe multi-year Quantum Leap program can structurally lower the manufacturing cost base, simplify operations, and improve working-capital efficiency. Its staged savings provide a durable support to margins and cash generation, while footprint consolidation may strengthen competitiveness across end markets.
Potential Entry Into Higher-growth Medical AdhesivesIf completed, the proposed AMS acquisition would increase exposure to surgical bonding and other medical applications, which management describes as a high-growth, high-margin market. That mix shift could reduce reliance on cyclical industrial and construction demand and improve long-term portfolio quality.
Bears Say
Weak Free-cash-flow Conversion Limits Financial FlexibilityReported earnings are not translating efficiently into cash, which can constrain debt reduction, investment, and shareholder returns. Persistently weak conversion would leave the company more dependent on operating improvements and asset actions to fund strategic priorities and absorb market volatility.
Meaningful Leverage And Additional AMS Financing Raise Balance-sheet RiskH.B. Fuller already carries a substantial debt burden, and financing AMS would increase leverage before planned deleveraging occurs. Higher interest expense and repayment demands could reduce flexibility for investment or downturn protection, particularly if industrial demand remains uneven.
Volume Weakness And Volatile Demand Undermine Consistent GrowthGrowth currently depends heavily on pricing because underlying volumes remain under pressure. Continued volume declines would limit operating leverage, make revenue less dependable, and increase execution demands around innovation, customer retention, and cost reductions across cyclical end markets.
H.B. Fuller Company News
HB1 FAQ
What was H.B. Fuller Company’s price range in the past 12 months?
H.B. Fuller Company lowest stock price was €42.00 and its highest was €57.00 in the past 12 months.
What is H.B. Fuller Company’s market cap?
H.B. Fuller Company’s market cap is €2.41B.
When is H.B. Fuller Company’s upcoming earnings report date?
H.B. Fuller Company’s upcoming earnings report date is Jan 20, 2027 which is in 106 days.
How were H.B. Fuller Company’s earnings last quarter?
H.B. Fuller Company released its earnings results on Sep 23, 2026. The company reported €1.355 earnings per share for the quarter, beating the consensus estimate of €1.306 by €0.049.
Is H.B. Fuller Company overvalued?
According to Wall Street analysts H.B. Fuller Company’s price is currently Undervalued.
Does H.B. Fuller Company pay dividends?
H.B. Fuller Company does not currently pay dividends.
What is H.B. Fuller Company’s EPS estimate?
H.B. Fuller Company’s EPS estimate is 1.21.
How many shares outstanding does H.B. Fuller Company have?
H.B. Fuller Company has 53,829,120 shares outstanding.
What happened to H.B. Fuller Company’s price movement after its last earnings report?
H.B. Fuller Company reported an EPS of €1.355 in its last earnings report, beating expectations of €1.306. Following the earnings report the stock price went down -1.81%.
Which hedge fund is a major shareholder of H.B. Fuller Company?
Currently, no hedge funds are holding shares in DE:HB1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H.B. Fuller Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€56.30 (14.43% Upside)
€56.30 (14.43% Upside)
Blogger Sentiment
Bullish
DE:HB1 Sentiment 71%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth €83.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.53%
12-Months-Change
Fundamentals
Return on Equity
1.87%
Trailing 12-Months
Asset Growth
5.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
H.B. Fuller Company
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
HB1 Company Deck
HB1 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive, with strong third-quarter revenue, EBITDA, margin, EPS, cash flow, segment performance, Quantum Leap execution, and progress toward closing the AMS acquisition. The main challenges were lower volumes, volatile demand, elevated raw material costs, supply chain disruption, weakness in electronics, construction, China, and portions of HHC and BAS. Management remained confident in continued growth, margin expansion, savings realization, cash flow improvement, and deleveraging.View all DE:HB1 earnings summariesHB1 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€56.30
▲(14.43% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ashland
―
Eastman Chemical
―
PPG Industries
―
RPM International
―
Axalta Coating Systems
―









